Synonym: PC; (7R)-4-Hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxohexadecyl)oxy]- 3,5,9-trioxa-4-phosphapentacosan-1-aminium 4-oxide, inner salt; 1,2-Dihexadecanoyl-sn-glycero-3-phosphocholine; 1,2-Dihexadecanoyl-sn-glycero-3-phosphorylcholine; 1,2-Dipalmitoyl-sn-glycero-3-phosphorylcholine; 1,2-Dipalmitoyl-L-lecithin; L-α-Phosphatidylcholine, dipalmitoyl; L-β,γ-Dipalmitoyl-α-lecithin; DPPC; PC(16:0/16:0)
CAS Number: 63-89-8
Empirical Formula (Hill Notation): C40H80NO8P
Molecular Weight: 734.04
EC Number: 200-567-6
MDL Number: MFCD00036903
Linear Formula: C40H80NO8P
Product Type: Chemical
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SKU: P4329-100MG
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SKU: P4329-1G
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SKU: P4329-500MG
| assay |
≥99% (TLC) |
| biological source |
synthetic |
| form |
powder |
| functional group |
phospholipid |
| InChI |
1S/C40H80NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-39(42)46-36-38(37-48-50(44,45)47-35-34-41(3,4)5)49-40(43)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h38H,6-37H2,1-5H3/t38-/m1/s1 |
| InChI key |
KILNVBDSWZSGLL-KXQOOQHDSA-N |
| lipid type |
phosphoglycerides |
| Quality Level |
200  |
| shipped in |
ambient |
| SMILES string |
[O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O)=O |
| storage temp. |
−20°C |
| Application: |
- Effects induced by (6)-p-cymene ruthenium(II) complexes on Langmuir monolayers mimicking cancer and healthy cell membranes do not correlate with their toxicity.: This study investigates the interaction of ruthenium(II) complexes with Langmuir monolayers, including 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine, highlighting differences in behavior between cancerous and healthy cell membrane models (Wrobel et al., 2024
 ).
- Cholesterol Changes Interfacial Water Alignment in Model Cell Membranes.: This study examines how cholesterol affects water alignment at the interface of model cell membranes that include 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine, offering insights into membrane biophysics (Orlikowska-Rzeznik et al., 2024
 ).
- Impact of Lipid Composition on Vesicle Protein Adsorption: A BSA Case Study.: The impact of different lipid compositions, including 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine, on the adsorption of bovine serum albumin to vesicles is studied to understand protein-lipid interactions (Amarandi et al., 2024
 ).
- Spatial Arrangement of the Drug Ibuprofen in a Model Membrane in the Presence of Lipid Rafts.: This paper investigates the arrangement of ibuprofen within model membranes containing lipid rafts and 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine, shedding light on drug-membrane interactions (Kashnik et al., 2024
 ).
|
| Other Notes: |
Purified by crystallization. |
| Packaging: |
1 g in poly bottle |
| Packaging: |
25, 100, 500 mg in poly bottle |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥99% (TLC) |
| Storage Temp. |
−20°C |
| UNSPSC |
12352211 |